The Aflac Cancer and Blood Disorders Center offers a wide array of services for children with cancer, bleeding and clotting disorders, and sickle cell disease.
Our resources are focused on four main approaches for fighting these diseases: a better understanding of the diseases’ origins, innovative therapy, blood and marrow transplantation as a special form of advanced treatment and childhood cancer survivorship.
- Pediatric Blood and Marrow Transplant (BMT) Program
A pediatric BMT is used to treat many types of life-threatening cancers and blood disorders. The Aflac Cancer Center performs an average of 60 pediatric blood and marrow transplants (BMTs) each year.
- Childhood Cancer Program
As a member of the largest pediatric clinical trials group in the world, Children’s Oncology Group, the Aflac Cancer Center offers the most current childhood cancer treatment available.
- Hematology Program
More than 2,500 children with sickle cell disease, hemophilia and other blood disorders are followed every year through the Aflac Cancer Center and Blood Disorders Service.
- Bleeding and Clotting Disorders
The Aflac Cancer Center follows more than 700 children with hemophilia and other bleeding disorders and approximately 200 with clotting disorders, such as thrombosis.
- Sickle Cell Disease Program
The Aflac Cancer Center follows more than 1,600 pediatric sickle cell patients in our comprehensive program.
- Innovative Therapy Program
The Aflac Cancer Center currently offers 13 Phase I trials and 15 Phase II trials for pediatric cancer patients.